In part, this could reflectthe lower within-patient variation for the CD4+ T cell count, and the fact thatthe CD4+ T cell count shows a better clinical prognostic value than the viralload, especially during the chronic phase of the infection (the disease stage mostof our study subjects are expected to be in) [48]. The gene discussed is CD4; the disease is infection.